Cardlytics, Inc. (CDLX) vs iOThree Limited Ordinary Shares (IOTR)

A side-by-side comparison of Cardlytics, Inc. and iOThree Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Cardlytics, Inc. logo
CDLX
Cardlytics, Inc.
$16M
$2.69Communication ServicesDelayed quote: Oct 6, 2026, 12:09 PM EDT
iOThree Limited Ordinary Shares logo
IOTR
iOThree Limited Ordinary Shares
$6M
$1.94Communication ServicesDelayed quote: Oct 6, 2026, 11:58 AM EDT

Total return — CDLX vs IOTR

growth of $100 · dividends reinvested · last 1y
CDLX -80.7% (-80.7%/yr)IOTR -94.7% (-94.7%/yr)CDLX compounded faster over this window
050100150200Start $1002026$19$5
CDLX IOTR

CDLX vs IOTR: by the numbers

  • •CDLX is the larger company ($16M vs $6M market cap).
  • •Both run net losses; IOTR's is the smaller (-7.89% vs -55.92% net margin).

Metrics side by side

Valuation

MetricCDLXIOTR
P/S ratio0.09N/A
P/B ratioN/A1.70

Profitability

MetricCDLXIOTR
Gross margin47.93%18.44%
Operating margin-20.21%-7.36%
Net margin-55.92%-7.89%
ROEN/A-26.02%
ROIC-46.24%-17.91%

Growth (annualized)

MetricCDLXIOTR
Revenue CAGR (5Y)4.53%N/A
Total return CAGR (5Y)-67.88%N/A

Go deeper

Full CDLX analysisFull IOTR analysisInteractive comparison tool

Dig into the metrics

Cardlytics ROEiOThree Limited Ordinary Shares ROECardlytics operating marginiOThree Limited Ordinary Shares operating marginCardlytics revenue growthiOThree Limited Ordinary Shares revenue growthCardlytics free cash flowiOThree Limited Ordinary Shares free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.